Preisträger
Hugo-Schottmüller-Preis 2012
cand. med. Philipp Rauch, München: Innate Response Activator B Cells Protect Against Microbial Sepsis. Science 3 February 2012:
Vol. 335 no. 6068 pp. 597-601.
Roger-Bone-Preis 2012
Dr. med. Martin Kolditz, Dresden: Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study. BMC Infectious Diseases 2012, 12:90.
B.Braun Critical Care Award 2012
Dr. rer. medic. Frank Schwab, Berlin: Understaffing, overcrowding, inappropriate nurse:ventilated patient ratio and nosocomial infections: which parameter is the best reflection of deficits? Journal of Hospital Infection Vol. 80, Issue 2, Pages 133-139.
Roger-Bone-Preis 2011
PD Dr. med. Michael Adamzik, Essen: Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Critical Care 2010, 14(5):R178
B.Braun Critical Care Award 2011
Dr. med. Michael Sasse, Hannover: Das pädiatrische Intensiv-Sepsisnetzwerk Norddeutschland.
Hugo-Schottmüller-Preis 2011
Dr. med. Valbona Mirakaj, Frankfurt/Main: Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation. Proceedings of the National Academy of Sciences of the United States of America (PNAS), April 19, 2011, vol. 108, no. 16,6555–6560
Roger-Bone-Preis 2010
Dr. Jörg C. Schefold, Berlin: Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. American Journal of Respiratory an Critical Care Medicine
Roger-Bone-Preis 2010
Dr. Christian Meisel, Berlin: Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. American Journal of Respiratory and Critical Care Medicine
B.Braun Critical Care Award 2010
PD Dr. med. Axel Kola, Berlin: Is there an association between nosocomial infection rates and bacterial cross transmissions?, Crit Care Med 2010 Vol. 38, No. 1
Hugo-Schottmüller-Preis 2010
Dr. Stephan Herzig, Heidelberg: In vivo PEPCK promoter mapping identifies disrupted hormonal synergism as a target of inflammation during sepsis in mice. Hepatology
Hugo-Schottmüller-Preis 2009
PD Dr. med. P. Rosenberger, Tübingen: Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nature Immunology
B.Braun Critical Care Award 2009
PD Dr. med. I. F. Chaberny, Hannover
Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies. Annals of Hematology
Hugo-Schottmüller-Preis 2008
PD Dr. T. Vogl, Münster: MRP8 and MRP14 are novel endogenous activators of toll-like receptor 4 promotinglethal endotoxin-induced shock, Nature Medicine 13: 1042-1049
Roger-Bone-Preis 2008
N. Rafat, Mannheim: Increased circulation endothelial progenitor cells in septic patients: Correlation with survival, Critical Care Medicine 2007; 35:1677-1684
B.Braun Critical Care Award 2008
Dr. I. Nachtigall, Berlin: Impact of Adherence to Standard Operating Pocedures for Pneumonia on Outcome of ICU Patients
Hugo-Schottmüller-Preis 2007
Dr. S. Wirtz, Mainz:
Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27, The Journal of Experimental
Medicine, 2006; 203: 1875-1881
Roger-Bone-Preis 2007
Dr. med. J. C. Schefold, Berlin: A novel selevtive extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin-6, and complement-activating product 5a, Shock 2007
B.Braun Research Award 2007
Dr. M. C. Bürle, Ludwigsburg: Regionales Netzwerk zur Umsetzung und Optimierung evidenz-basierter Therapien in der klinischen Intensivmedizin
Hugo-Schottmüllerpreis 2006
Prof. L. Schaefer, Frankfurt: The Matrix component biglycan is proinflammatory and signals through Toll-like receptor-4 and -2 in magrophages. The Journal of Clinical Investication 2005, Vol. 115, No. 8: 2223-2233.
Roger-Bone-Preis 2006
PD Dr. med. M. Westphal, Münster: Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study. Critical Care Medicine 2006, Vol. 34, No. 9: 2287-2293.
B.Braun Critical Care Award 2006
Dr. med. F. Rinderknecht, Göppingen: Standard Operating Procedures (SOPs) - Mittel zur Einführung und Implementierung evidenzbasierter Therapiestrategien in der Intensivmedizin.
Forschungsstipendium 2006
PD Dr. med. Dr. rer. Nat Dipl. Phys. O. Friedrich, Heidelberg: Pathogenese der Myopathie bei Intensivpatienten.
Hugo-Schottmüller-Preis 2005
Dr. P. Knüfermann, Bonn: Toll-like Receptor 2 Mediates Staphylococcus aureus-Induced Myocardial Dysfunction and Cytokine Production in the Heart. Circulation, 2005; 110:3693-3698
Roger-Bone Preis 2005
Dr. M. Brückmann; Mannheim: Prognostic value of plasma N-terminal pro brain natriuretic peptide in patients with severe sepsis. Circulation, 2005;112: 527-534
B. Braun Critical Care Award
Dr. A. Kortgen, Homburg/Saar: Implementation of an evidence-based "standard operating procedure" and outcome. Critical Care Medicine, 2006; 34:943
Forschungsstipendium 2005
Dr. med. J. Glatzle, Tübingen: Protektive Effekte einer enteralen Immunonutrition auf die Entstehung von septischen Lungenfunktionsstörungen
Hugo-Schottmüller-Preis 2004
Dr. med. W. Merx, Aachen: HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis. Circulation 2004;109:2560-2565.
Roger-Bone Preis 2004
Dr. med. K. Mayer, Gießen: Parenteral Nutrition with Fish Oil Modulates Cytokine Response in Patients with Sepsis. Am J Respir Crit Care Med 2003;167:1321-1328.
Forschungsstipendium 2004
Dr. med. Ch. Gille, Tübingen: Etablierung eines Assays zur Quantifizierung der bakteriellen Phagoyztosekapazität von Makrophagen bei neonataler Sepsis.
Hugo-Schottmüller-Preis 2003
Dr. med. Ph. Henneke: Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways. J Immunol 2002; 169:3970-3977
&
Dr. med. N. C. Riedemann: Regulation by C5a of Neutrophil Activation during Sepsis. Immunity 2003; 19:193-202
Roger-Bone Preis 2003
Dr. med. D. Keh: Immunologic and Hemodynamic Effects of "Low-dose" Hydrocortisone in Septic Shock: a Double-Blind, Randomized, Placebo-controlled, Crossover Study. Am J Respir Crit Care Med 2003;167(4):512-20
Hugo-Schottmüller-Preis 2002
Dr. med. Uwe Senftleben: Habilitationsschrift "Funktion des IKK/NF-kB Signaltransduktionsweges bei der Lymphopoese" u.a. erschienen in: Science, Vol. 293 (24 August 2001)
Roger-Bone Preis 2002
Dr. med. M. Huber-Lang: Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB J, 15 (2001)
&
Dr. med. J. Zweigner: High concentrations of lipopolysaccharide-binding protein (LBP) in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood, 89 (2001)